Update on Metastatic Squamous Non-Small Cell Lung Cancer

EP. 1: EGFR & ALK/ROS1 Testing in Squamous NSCLC

February 21st 2017

EP. 2: PD-L1 Testing in Squamous NSCLC

February 21st 2017

EP. 3: Pembrolizumab in Newly Diagnosed Squamous NSCLC

February 21st 2017

EP. 4: Toxicities Associated with Anti-PD-1 Immunotherapy

February 21st 2017

EP. 5: Pseudoprogression on Immunotherapy in Squamous NSCLC

February 21st 2017

EP. 6: Promising Immunotherapy Trials in Squamous NSCLC

February 21st 2017

EP. 7: Chemotherapy for Newly Diagnosed Squamous NSCLC

February 21st 2017

EP. 8: Maintenance Therapy for Squamous NSCLC

February 21st 2017

EP. 9: Choosing Second-Line Therapy for Squamous NSCLC

February 21st 2017

EP. 10: Further Sequencing in Squamous NSCLC

February 21st 2017

EP. 11: EGFR-Targeted Therapy for Squamous NCSLC

February 21st 2017

EP. 12: Final Thoughts on Squamous NSCLC Research

February 21st 2017